XENE - Xenon Pharmaceuticals Inc.

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

XENE - Xenon Pharmaceuticals Inc.

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Fri 19'th Oct 2018

PERIOD 2018-07-20 - 2018-10-19
CHANGE -2.23%
PRICE $10.51





Request Prediction

Xenon Pharmaceuticals Inc. Stock Analysis

Technical stock analysis for Fri 19'th Oct 2018

Sell candidate since 2018-10-17 Loss -3.04%
Shorts 0.87% ( 2018-09-28 )
Cash 43.8 mill
Loans n/a
Beta 1.12
ROA -44.07

Xenon Pharmaceuticals Inc. fell by -2.23% in the last day from $10.75 to $10.51 and has now fallen 4 days in a row. The price has fallen in 7 of the last 10 days and is down by -8.85% for this period. Volume has increased in the last day by 44 792 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 101 947 shares bought and sold for approximately $1.07 million.


Xenon Pharmaceuticals Inc. lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $10.21 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 12.96% during the next 3 months and, with 90% probability hold a price between $11.53 and $17.72 at the end of this period.

Click here for today's Top 5 Trending Companies


There are few to none technical positive signals at the moment. Xenon Pharmaceuticals Inc. holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $10.59 and $12.55. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Tuesday October 16, 2018, which indicates further falls until a new bottom pivot has been found. Xenon Pharmaceuticals Inc. gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 32 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Xenon Pharmaceuticals Inc. finds support from accumulated volume at $10.48.

Support: $10.48 Price: $10.51 Resistance: $11.00


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.41 between high and low, or 3.90%. For the last week, the stock has had a daily average volatility of 4.87%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High


The Xenon Pharmaceuticals Inc. stock holds several negative signals and despite the positive trend we believe Xenon Pharmaceuticals Inc. will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Sell Candidate

Click for Top 5 Sell Candidates
XENE $10.51 $-0.24(-2.23%)
XENE is down $0.24 today, but where's it headed in November?
Zacks Investment Research is releasing its prediction for XENE based on the 1-3 month system that more than doubles the S&P 500.

Click here – the XENE analysis is free »

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at

in partnership with